CYTARABINE and PYREXIA

Overview

PYREXIA is the #3 most commonly reported adverse reaction for CYTARABINE, manufactured by Fresenius Kabi USA, LLC. There are 4,012 FDA adverse event reports linking CYTARABINE to PYREXIA. This represents approximately 3.7% of all 108,092 adverse event reports for this drug.

Patients taking CYTARABINE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is moderately reported among CYTARABINE users, representing a notable but not dominant share of adverse events.

Other Side Effects of CYTARABINE

In addition to pyrexia, the following adverse reactions have been reported for CYTARABINE:

• FEBRILE NEUTROPENIA — 7,376 reports
• OFF LABEL USE — 4,870 reports
• NEUTROPENIA — 3,559 reports
• DRUG INEFFECTIVE — 3,063 reports
• SEPSIS — 2,897 reports
• THROMBOCYTOPENIA — 2,835 reports
• DISEASE PROGRESSION — 2,693 reports
• PNEUMONIA — 2,258 reports
• PANCYTOPENIA — 2,055 reports
• DEATH — 1,995 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does CYTARABINE cause PYREXIA?

PYREXIA has been reported as an adverse event in 4,012 FDA reports for CYTARABINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with CYTARABINE?

PYREXIA accounts for approximately 3.7% of all adverse event reports for CYTARABINE, making it one of the most commonly reported side effect.

What should I do if I experience PYREXIA while taking CYTARABINE?

If you experience pyrexia while taking CYTARABINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages